Merus Gestione
Gestione criteri di controllo 4/4
Merus Il CEO è Bill Lundberg, nominato in Dec2019, e ha un mandato di 4.92 anni. la retribuzione annua totale è $ 4.67M, composta da 13.9% di stipendio e 86.1% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.22% delle azioni della società, per un valore di $ 6.53M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.8 anni e 6.3 anni.
Informazioni chiave
Bill Lundberg
Amministratore delegato
US$4.7m
Compenso totale
| Percentuale dello stipendio del CEO | 13.9% |
| Mandato del CEO | 4.9yrs |
| Proprietà del CEO | 0.2% |
| Durata media del management | 2.8yrs |
| Durata media del Consiglio di amministrazione | 6.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Merus: Petosemtamab Set Up For December 2024 Data Presentation
Nov 05We're Hopeful That Merus (NASDAQ:MRUS) Will Use Its Cash Wisely
Sep 20
Merus N.V.'s Innovative Cancer Therapies: Balancing Its IP Potential With Financial Risks
Aug 14Analysts Just Made A Major Revision To Their Merus N.V. (NASDAQ:MRUS) Revenue Forecasts
Jun 01Merus Stock: Priced High After An ASCO Surprise Surge (Maintain Buy)
May 24Earnings Beat: Merus N.V. (NASDAQ:MRUS) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
May 12Merus (NASDAQ:MRUS) Is In A Good Position To Deliver On Growth Plans
May 10Merus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancement
Mar 01Merus N.V.'s (NASDAQ:MRUS) Shares Climb 30% But Its Business Is Yet to Catch Up
Feb 01Merus Stock: Rally Seems Overdone
Jan 23Are Investors Undervaluing Merus N.V. (NASDAQ:MRUS) By 45%?
Jan 14Risks To Shareholder Returns Are Elevated At These Prices For Merus N.V. (NASDAQ:MRUS)
Dec 18We Think Merus (NASDAQ:MRUS) Needs To Drive Business Growth Carefully
Sep 19Merus N.V.'s (NASDAQ:MRUS) Business Is Yet to Catch Up With Its Share Price
Jun 20Is Merus (NASDAQ:MRUS) In A Good Position To Invest In Growth?
May 24Merus N.V. (NASDAQ:MRUS) Shares Could Be 26% Below Their Intrinsic Value Estimate
Feb 08Merus GAAP EPS of -$0.13 beats by $0.49, revenue of $12.68M beats by $2.23M
Aug 08Merus N.V. initiated with Buy at Stifel based on three bispecific antibodies
Aug 02Merus: Precision Oncology Pioneer Continues To Execute In The Clinic
Jun 30Need To Know: Analysts Are Much More Bullish On Merus N.V. (NASDAQ:MRUS)
May 14Merus (NASDAQ:MRUS) Is In A Strong Position To Grow Its Business
Apr 25New Forecasts: Here's What Analysts Think The Future Holds For Merus N.V. (NASDAQ:MRUS)
Mar 03We're Not Worried About Merus' (NASDAQ:MRUS) Cash Burn
Nov 25News Flash: Analysts Just Made A Sizeable Upgrade To Their Merus N.V. (NASDAQ:MRUS) Forecasts
Aug 08Calculating The Intrinsic Value Of Merus N.V. (NASDAQ:MRUS)
Jul 28We're Not Very Worried About Merus' (NASDAQ:MRUS) Cash Burn Rate
Jul 02Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$245m |
| Jun 30 2024 | n/a | n/a | -US$168m |
| Mar 31 2024 | n/a | n/a | -US$150m |
| Dec 31 2023 | US$5m | US$650k | -US$155m |
| Sep 30 2023 | n/a | n/a | -US$177m |
| Jun 30 2023 | n/a | n/a | -US$178m |
| Mar 31 2023 | n/a | n/a | -US$152m |
| Dec 31 2022 | US$6m | US$599k | -US$131m |
| Sep 30 2022 | n/a | n/a | -US$64m |
| Jun 30 2022 | n/a | n/a | -US$54m |
| Mar 31 2022 | n/a | n/a | -US$76m |
| Dec 31 2021 | US$8m | US$582k | -US$67m |
| Sep 30 2021 | n/a | n/a | -US$80m |
| Jun 30 2021 | n/a | n/a | -US$89m |
| Mar 31 2021 | n/a | n/a | -US$79m |
| Dec 31 2020 | US$5m | US$565k | -US$86m |
| Sep 30 2020 | n/a | n/a | -US$83m |
| Jun 30 2020 | n/a | n/a | -US$69m |
| Mar 31 2020 | n/a | n/a | -US$65m |
| Dec 31 2019 | US$162k | n/a | -US$55m |
Compensazione vs Mercato: La retribuzione totale di Bill ($USD 4.67M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 6.60M ).
Compensazione vs guadagni: La retribuzione di Bill è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Bill Lundberg (61 yo)
4.9yrs
Mandato
US$4,671,327
Compensazione
Dr. Sven Ante Lundberg, also known as Bill, M.D. is Venture Advisor of Forge Life Science Partners. He serves as Chief Executive Officer, President and Executive Director of Merus N.V. since December 31, 2...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, President & Executive Director | 4.9yrs | US$4.67m | 0.22% $ 6.5m | |
| Chief Financial Officer | 1.4yrs | US$6.21m | 0% $ 0 | |
| EVP, Company Secretary | 6.8yrs | US$1.95m | Nessun dato | |
| Co-Founder and Scientific Advisor | no data | Nessun dato | Nessun dato | |
| Chief Accounting Officer | no data | Nessun dato | 0.010% $ 300.7k | |
| CTO & Executive VP | 11.8yrs | US$609.22k | Nessun dato | |
| Chief Scientific Officer & Senior VP | 3.5yrs | Nessun dato | Nessun dato | |
| IR & Corporate Communications Officer | no data | Nessun dato | Nessun dato | |
| Chief People Officer | no data | Nessun dato | Nessun dato | |
| Executive VP & Chief Commercial Officer | 2.8yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Regulatory Affairs | 2.8yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Clinical Development | 2.8yrs | Nessun dato | Nessun dato |
2.8yrs
Durata media
59yo
Età media
Gestione esperta: Il team dirigenziale di MRUS è considerato esperto (durata media dell'incarico 2.8 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, President & Executive Director | 5.4yrs | US$4.67m | 0.22% $ 6.5m | |
| Board Observer | 14.8yrs | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 3.5yrs | US$305.06k | 0% $ 0 | |
| Independent Chairman | 9.3yrs | US$417.56k | 0% $ 0 | |
| Independent Non-Executive Director | 4.4yrs | US$309.56k | 0% $ 0 | |
| Independent Non Executive Director | 9.4yrs | US$311.06k | 0.11% $ 3.2m | |
| Member of Scientific Advisory Board | 6.3yrs | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 5.4yrs | US$303.56k | 0% $ 0 | |
| Member of Scientific Advisory Board | 6.3yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 6.3yrs | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | less than a year | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 6.3yrs | US$303.56k | 0% $ 0 |
6.3yrs
Durata media
59.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MRUS sono considerati esperti (durata media dell'incarico 6.3 anni).